Analytical Data
-
Gene name
TMEM200A
- Application
-
Alternative Names
TMEM200A; KIAA1913; HBE61; Transmembrane Protein 200A
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q86VY9
-
Expression Region
1-491 aa
-
AA Sequence
MIATGGVITGLAALKRQDSARSQQHVNLSPSPATQEKKPIRRRPRADVVVVRGKIRLYSPSGFFLILGVLISIIGIAMAVLGYWPQKEHFIDAETTLSTNETQVIRNEGGVVVRFFEQHLHSDKMKMLGPFTMGIGIFIFICANAILHENRDKETKIIHMRDIYSTVIDIHTLRIKEQRQMNGMYTGLMGETEVKQNGSSCASRLAANTIASFSGFRSSFRMDSSVEEDELMLNEGKSSGHLMPPLLSDSSVSVFGLYPPPSKTTDDKTSGSKKCETKSIVSSSISAFTLPVIKLNNCVIDEPSIDNITEDADNLKSRSRNLSMDSLVVPLPNTSESFQPVSTVLPRNNSIGESLSSQYKSSMALGPGAGQLLSPGAARRQFGSNTSLHLLSSHSKSLDLDRGPSTLTVQAEQRKHPSWPRLDRNNSKGYMKLENKEDPMDRLLVPQVAIKKDFTNKEKLLMISRSHNNLSFEHDEFLSNNLKRGTSETRF
-
Molecular Weight
80.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TMEM200A, a member of the transmembrane protein family, has gained attention for its potential role in various cellular processes and diseases. Emerging evidence suggests that TMEM200A is involved in the regulation of cell signaling pathways, particularly in contexts related to cancer and neurodegenerative disorders. Its expression patterns have been found to be altered in several types of tumors, indicating a possible involvement in tumorigenesis and progression. Additionally, TMEM200A is thought to participate in cellular responses to stress, suggesting a protective role in maintaining cellular homeostasis. Reconstructing TMEM200A as a recombinant protein can facilitate the exploration of its functional properties and interactions with other proteins, paving the way for the development of targeted therapeutic strategies. Furthermore, understanding its structure and function could provide insights into the molecular mechanisms underlying its association with disease states. As researchers continue to dissect the biological significance of TMEM200A, the recombinant protein offers a valuable tool for investigating its role in health and disease, potentially leading to advancements in targeted therapies and personalized medicine.
